HALIX R&D and production facility

With an official inauguration ceremony, HALIX celebrated the opening of its brand-new cGMP facility at the Leiden Bio Science Park. Alex Huybens (HALIX) and Paul Dirkse (Alderman of the municipality of Leiden) ceremoniously opened the new facility. The new building houses facilities for the development and manufacturing of biopharmaceuticals. The high tech building is designed by EGM within the team of main contractor Kuijpers.

Research & development and production

The new five-level production facility measures 6,700 m² and contains a state-of-the-art manufacturing line for viral vaccines and viral vectors, starting soon, with a 250 L bioreactor scale. A separate protein manufacturing area with a capacity up to 1,000 L single-use bioreactors is available. Laboratory spaces within the facility enable process development and transfer, analytical development and quality control of biopharmaceuticals.

The facility is a symbol for the strong innovative, dynamic and modern culture at HALIX

Alex Huybens, COO of HALIX

HALIX - bioscience as a service

HALIX is licensed for the contract manufacturing of clinical and commercial medicines according to Current Good Manufacturing Practice (cGMP) standards. As an end-to-end service provider, it will serve its customers the full range from the first development steps to start of commercial production after successful registration of products. The facility is designed and equipped according to latest biopharmaceutical quality standards. All BSL2 cleanrooms are structured according to the unidirectional process flow of personal and materials and prepared for an upgrade to BSL3, if required. The office spaces, laboratory and cleanroom areas offer up to 70 employees attractive and modern workplaces.

Partners

The new facility for HALIX has been realized by Kuijpers and its partners EGM architects, DuPrie Bouw, Cleanroom Combination Group en IMd Raadgevende Ingenieurs.

_{Photography: Kuijpers, EGM architects, Erika Gallegos}